Acumen Pharmaceuticals, Inc. (ABOS)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 2900
-0.08
-3.38%
$
153.86M Market Cap
- P/E Ratio
- Div Yield
298,417 Volume
- Eps
$ 2.37
Previous Close Want to track ABOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acumen Pharmaceuticals, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 67,375 | $149,913.6 | $154,288.75 | $4,375.15 | 2.92% |
| CCP Christopher C. Powers Farther Finance Advisors, LLC | 200 | $232 | $458 | $226 | 97.41% |
| CAL Clune & Associates Ltd. Clune & Associates Ltd. | 16,500 | $28,380 | $37,785 | $9,405 | 33.14% |
